Impact of Fortified Rice on Workers' Nutrition Status

February 4, 2021 updated by: DSM Nutritional Products, Inc.

Study to Evaluate the Efficacy of Fortified Rice on Hemoglobin Levels and Levels of Vitamins and Minerals in Healthy Asian Migrant Workers in Singapore

The study is a single center, open label, nutrition intervention study. Healthy adult male working at a Singapore construction site are included if they fulfill inclusion and exclusion criteria. Volunteers receive fortified rice for their daily lunch and dinner each day of the week (i e 14 meals/week) over six months. Nutrition status in blood is measured at baseline and after six months of fortified rice consumption.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study is a single center, open label, uncontrolled longitudinal nutrition intervention study. Migrant construction workers of either Bangladeshi or Indian ethnicity from a single dormitory in Singapore volunteer to participate at the study. Only eligible workers are included in the study if they fulfilled all inclusion and exclusion criteria; 20 and 51 years old, a BMI between 17.0 to 27.5 kg/m2, willing to adhere to the study procedure for at least six months, and sign informed consent, are free of current medical and/or chronic/non communicable diseases, no history of heavy smoking or alcohol consumption. The eligible subjects receive fortified rice for their daily lunch and dinner each day of the week (i e 14 meals/week) over six months. The nutrient levels per 100 g fortified rice contain 150 µg vitamin A (Vitamin A palmitate), 0.5 mg vitamin B1 (thiamin mononitrate), 7 mg vitamin B3 (niacin amide), 0.6 mg vitamin B6 (pyridoxine hydrochloride), 1 µg vitamin B12 (cyanocobalamin), 130 µg folic acid, 4 mg iron (ferric pyrosphosphate), and 6 mg zinc (zinc oxide). At baseline and after 6 months of intervention, BMI and vital signs such as blood pressure, pulse and body temperature are collected. Also, 10 ml venous blood is sampled at baseline and after 6 months of intervention and subsequently tested for hemoglobin, serum folate, and serum zinc, serum ferritin and serum vitamin B12 status. In a small subset of the migrant construction workers, an extra 5 ml blood sample is taken for homocysteine testing.

Study Type

Interventional

Enrollment (Actual)

133

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 118264
        • SPRIM

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • 20 Years to 51 Years
  • Indian or Bangladeshi ethnic origin
  • BMI of 17.0 to 27.5 kg/m2
  • Working at the construction site and continuing for 6 months after enrollment
  • Willing and able to adhere to study procedures
  • Signed the informed consent form

Exclusion Criteria:

  • Conditions or diseases that the investigator considers to be not appropriate to enter the study
  • Chronic illness
  • History of heavy smoking (more than 10 cigarettes/day continuously for two years or more (self-reported) )
  • Unable to understand informed consent (translated to Tamil and Bangladesh at basic literacy level)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fortified rice
fortified rice for daily lunch and dinner each day of the week (i.e. 14 meals/week) for six months
100 g of rice was fortified with 150 µg vitamin A (Vitamin A palmitate), 0.5 mg vitamin B1 (thiamin mononitrate), 7 mg vitamin B3 (niacin amide), 0.6 mg vitamin B6 (pyrodoxine hydrochloride), 1 µg vitamin B12 (cyanocobalamin), 130 µg folic acid, 4 mg iron (ferric pyrosphosphate), and 6 mg zinc (zinc oxide).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hemoglobin status
Time Frame: From baseline to 6 months
Hemoglobin concentration in blood
From baseline to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Folate status
Time Frame: From baseline to 6 months
Red blood cell folate concentration in serum
From baseline to 6 months
Zinc status
Time Frame: From baseline to 6 months
Serum zinc concentration
From baseline to 6 months
Iron status
Time Frame: From baseline to 6 months
Serum ferritin concentration
From baseline to 6 months
Vitamin B12 status
Time Frame: From baseline to 6 months
Serum vitamin B12 concentration
From baseline to 6 months
Homocysteine status
Time Frame: From baseline to 6 months
Serum homocysteine concentration
From baseline to 6 months
BMI
Time Frame: From baseline to 6 months
BMI calculated from height and weight
From baseline to 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: From baseline to 6 months
Height (cm)
From baseline to 6 months
Weight
Time Frame: From baseline to 6 months
Weight (kg)
From baseline to 6 months
Blood pressure
Time Frame: From baseline to 6 months
Systolic and Diastolic Blood Pressure (mmHg)
From baseline to 6 months
Pulse
Time Frame: From baseline to 6 months
Pulse (count/min)
From baseline to 6 months
Body temperature
Time Frame: From baseline to 6 months
Body temperature (degrees Celsius)
From baseline to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 11, 2018

Primary Completion (Actual)

September 30, 2018

Study Completion (Actual)

September 30, 2018

Study Registration Dates

First Submitted

April 9, 2020

First Submitted That Met QC Criteria

April 9, 2020

First Posted (Actual)

April 13, 2020

Study Record Updates

Last Update Posted (Actual)

February 9, 2021

Last Update Submitted That Met QC Criteria

February 4, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • OBVO-0104DSM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nutrient Deficiency

Clinical Trials on Fortified rice

3
Subscribe